Elsa S. Strotmeyer

Elsa S. Strotmeyer

Auto-generated profile, based on publicly available information

Elsa S. Strotmeyer

Department of Epidemiology, School of Public Health, University of Pittsburgh , Pittsburgh, PA 15261

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
SPSeok Won Park
Seok Won Park
BGBret H. Goodpaster
Bret H. Goodpaster
ESElsa S. Strotmeyer
Elsa S. Strotmeyer
LKLewis H. Kuller
Lewis H. Kuller
RBRobert Broudeau
Robert Broudeau
ANAnne B. Newman
Anne B. Newman
OBJECTIVE—It has been shown that adults with either long-standing type 1 or type 2 diabetes had lower skeletal muscle strength than nondiabetic adults in cross-sectional studies. The aim of the study was to investigate longitudinal changes of muscle mass and strength in community-dwelling older adults with and without type 2 diabetes.

1 June 2011 in JAMA
Verified
Journal Article
Open access
PDF file
ASAnn V. Schwartz
Ann V. Schwartz
EVEric Vittinghoff
Eric Vittinghoff
DBDouglas C. Bauer
Douglas C. Bauer
THTeresa A. Hillier
Teresa A. Hillier
ESElsa S. Strotmeyer
Elsa S. Strotmeyer
DBDennis M. Black
Dennis M. Black
Prevention of fractures is an important goal in older adults. It is increasingly recognized that adults with type 2 diabetes mellitus (DM), an estimated 17% of older adults in the United States,1 have a higher fracture rate.2-6 Preventive identification of adults at higher fracture risk is based on bone mineral density (BMD) T scores, used alone or in the World Health Organization (WHO) Fracture Risk Algorithm (FRAX) score.7 However, because type 2 DM is paradoxically associated with higher BMD and increased fracture risk,2 there is concern that these established methods for predicting fractures may not perform adequately in patients with type 2 DM.8,9 There is a need to clarify the use of standard methods for assessing fracture risk in this expanding population of older adults.

1 June 2006 in Diabetes
Verified
Journal Article
Open access
PDF file
SPSeok Won Park
Seok Won Park
BGBret H. Goodpaster
Bret H. Goodpaster
ESElsa S. Strotmeyer
Elsa S. Strotmeyer
NRNathalie de Rekeneire
Nathalie de Rekeneire
THTamara B. Harris
Tamara B. Harris
ANAnne B. Newman
Anne B. Newman
Adequate skeletal muscle strength is essential for physical functioning and low muscle strength is a predictor of physical limitations. Older adults with diabetes have a two- to threefold increased risk of physical disability. However, muscle strength has never been investigated with regard to diabetes in a population-based study. We evaluated grip and knee extensor strength and muscle mass in 485 older adults with diabetes and 2,133 without diabetes in the Health, Aging, and Body Composition study. Older adults with diabetes had greater arm and leg muscle mass than those without diabetes because they were bigger in body size. Despite this, muscle strength was lower in men with diabetes and not higher in women with diabetes than corresponding counterparts. Muscle quality, defined as muscle strength per unit regional muscle mass, was significantly lower in men and women with diabetes than those without diabetes in both upper and lower extremities. Furthermore, longer duration of diabetes (≥6 years) and poor glycemic control (HbA1c >8.0%) were associated with even poorer muscle quality. In conclusion, diabetes is associated with lower skeletal muscle strength and quality. These characteristics may contribute to the development of physical disability in older adults with diabetes.

1 September 2006 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
DBDenise E. Bonds
Denise E. Bonds
JLJoseph C. Larson
Joseph C. Larson
ASAnn V. Schwartz
Ann V. Schwartz
ESElsa S. Strotmeyer
Elsa S. Strotmeyer
JRJohn Robbins
John Robbins
KMKaren L. Margolis
Karen L. Margolis
Context: Some but not all studies have shown higher rates of fracture in individuals with type 2 diabetes. Objective: The objective of the study was to determine the risk of fracture in postmenopausal women with type 2 diabetes and determine whether risk varies by fracture site, ethnicity, and baseline bone density. Design, Setting, and Participants: Women with clinically diagnosed type 2 diabetes at baseline in the Women’s Health Initiative Observational Cohort, a prospective study of postmenopausal women (n = 93,676), were compared with women without diagnosed diabetes and risk of fracture overall and at specific sites determined. Main Outcome Measures: All fractures and specific sites separately (hip/pelvis/upper leg; lower leg/ankle/knee; foot; upper arm/shoulder/elbow; lower arm/wrist/hand; spine/tailbone) were measured. Bone mineral density (BMD) in a subset also was measured. Results: The overall risk of fracture after 7 yr of follow-up was higher in women with diabetes at baseline after controlling for multiple risk factors including frequency of falls [adjusted relative risk (RR) 1.20, 95% confidence interval (CI) 1.11–1.30]. In a subsample of women with baseline BMD scores, women with diabetes had greater hip and spine BMD. The elevated fracture risk was found at multiple sites (hip/pelvis/upper leg; foot; spine/tailbone) among black women (RR 1.33, 95% CI 1.00–1.75) and women with increased baseline bone density (RR 1.26, 95% CI 0.96–1.66). Conclusion: Women with type 2 diabetes are at increased risk for fractures. This risk is also seen among black and non-Hispanic white women after adjustment for multiple risk factors including frequent falls and increased BMD (in a subset).

1 September 2006 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ASAnn V. Schwartz
Ann V. Schwartz
DSDeborah E. Sellmeyer
Deborah E. Sellmeyer
EVEric Vittinghoff
Eric Vittinghoff
LPLisa Palermo
Lisa Palermo
BLBeata Lecka-Czernik
Beata Lecka-Czernik
SCSteven R. Cummings
Steven R. Cummings
Context: Activation of peroxisome proliferator-activated receptor-γ by thiazolidinediones (TZDs) results in lower bone mass in mice. Objective: The objective of the study was to determine whether TZD use is associated with changes in bone mineral density (BMD) in older adults with type 2 diabetes. Design: We analyzed 4-yr follow-up data from the Health, Aging, and Body Composition observational study. Setting: The study was conducted in a general community. Patients: White and black, physically able men and women, aged 70–79 yr at baseline with diabetes defined by self-report, use of hypoglycemic medication, elevated fasting glucose (≥126 mg/dl), or elevated 2-h glucose tolerance test (≥200 mg/dl) participated in the study. Main Outcome Measures: Whole-body, lumbar spine (derived from whole body), and hip BMD were measured by dual-energy x-ray absorptiometry at 2-yr intervals. Results: Of 666 diabetic participants, 69 reported TZD use at an annual visit, including troglitazone (n = 22), pioglitazone (n = 30), and/or rosiglitazone (n = 31). Those with TZD use had higher baseline hemoglobin A1c and less weight loss over 4 yr but similar baseline BMD and weight than others with diabetes. In repeated-measures models adjusted for potential confounders associated with TZD use and BMD, each year of TZD use was associated with greater bone loss at the whole body [additional loss of −0.61% per year; 95% confidence interval (CI) −1.02, −0.21% per year], lumbar spine (−1.23% per year; 95% CI −2.06, −0.40% per year), and trochanter (−0.65% per year; 95% CI −1.18, −0.12% per year) in women, but not men, with diabetes. Conclusion: These observational results suggest that TZDs may cause bone loss in older women. These results need to be tested in a randomized trial.

1 March 2008 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
ASAnn V. Schwartz
Ann V. Schwartz
EVEric Vittinghoff
Eric Vittinghoff
DSDeborah E. Sellmeyer
Deborah E. Sellmeyer
KFKenneth R. Feingold
Kenneth R. Feingold
NRNathalie de Rekeneire
Nathalie de Rekeneire
THTamara B. Harris
Tamara B. Harris
OBJECTIVE—Older adults with type 2 diabetes are more likely to fall, but little is known about risk factors for falls in this population. We determined whether diabetes-related complications or treatments are associated with risk of falls in older diabetic adults. RESEARCH DESIGN AND METHODS—In the Health, Aging, and Body Composition cohort of well-functioning older adults, participants reported falls in the previous year at annual visits. Odds ratios (ORs) for more frequent falls among 446 diabetic participants whose mean age was 73.6 years, with an average follow-up of 4.9 years, were estimated with continuation ratio models. RESULTS—In the first year, 23% reported falling; 22, 26, 30, and 31% fell in subsequent years. In adjusted models, reduced peroneal nerve response amplitude (OR 1.50 −95% CI 1.07–2.12], worst quartile versus others); higher cystatin-C, a marker of reduced renal function (1.38 [1.11–1.71], for 1 SD increase); poorer contrast sensitivity (1.41 [0.97–2.04], worst quartile versus others); and low A1C in insulin users (4.36 [1.32–14.46], A1C ≤6 vs. >8%) were associated with risk of falls. In those using oral hypoglycemic medications but not insulin, low A1C was not associated with risk of falls (1.29 [0.65–2.54], A1C ≤6 vs. >8%). Adjustment for physical performance explained some, but not all, of these associations. CONCLUSIONS—In older diabetic adults, reducing diabetes-related complications may prevent falls. Achieving lower A1C levels with oral hypoglycemic medications was not associated with more frequent falls, but, among those using insulin, A1C ≤6% increased risk of falls.